1. Home
  2. NBHC vs NVCR Comparison

NBHC vs NVCR Comparison

Compare NBHC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$43.10

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.55

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBHC
NVCR
Founded
2009
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
NBHC
NVCR
Price
$43.10
$17.55
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$47.67
$28.08
AVG Volume (30 Days)
452.2K
1.7M
Earning Date
04-21-2026
04-30-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
21.79
EPS
1.04
N/A
Revenue
$47,100,000.00
$655,353,000.00
Revenue This Year
$39.96
$7.72
Revenue Next Year
$7.14
$6.74
P/E Ratio
$41.86
N/A
Revenue Growth
2.86
8.28
52 Week Low
$35.06
$9.82
52 Week High
$47.28
$21.45

Technical Indicators

Market Signals
Indicator
NBHC
NVCR
Relative Strength Index (RSI) 47.09 55.77
Support Level $42.95 $14.84
Resistance Level $43.98 $18.48
Average True Range (ATR) 0.73 0.73
MACD 0.03 0.15
Stochastic Oscillator 55.49 87.80

Price Performance

Historical Comparison
NBHC
NVCR

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: